Inventor
LIN CHU-CHUNG
TW12 patents
⚠️ This page may combine multiple inventors who share the name “LIN CHU-CHUNG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NAT HEALTH RESEARCH INSTITUTES
6 patentsUS6903104B2Jun 7, 2005
Indol-3-YL-2-oxoacetamide compounds and methods of use thereof
NAT HEALTH RESEARCH INSTITUTES15 citations91
US7396838B2Jul 8, 2008
Use of 1H-indol-3-yl-2-oxoacetamide compounds
NAT HEALTH RESEARCH INSTITUTES2 citations61
US7662834B2Feb 16, 2010
Methods of 1H-indol-3-yl-2-oxoacetamide compounds
NAT HEALTH RESEARCH INSTITUTES0 citations50
US7569596B2Aug 4, 2009
Imidazolamino compounds
NAT HEALTH RESEARCH INSTITUTES0 citations50
US7462723B2Dec 9, 2008
Imidazolamino compounds
NAT HEALTH RESEARCH INSTITUTES0 citations50
US7109227B2Sep 19, 2006
Imidazolamino compounds
NAT HEALTH RESEARCH INSTITUTES0 citations50
TAIGEN BIOTECHNOLOGY CO LTD
5 patentsUS10004719B1Jun 26, 2018
Solid dispersion formulation
TAIGEN BIOTECHNOLOGY CO LTD12 citations83
US7183413B2Feb 27, 2007
Aminoquinoline compounds
TAIGEN BIOTECHNOLOGY CO LTD18 citations80
US10596171B2Mar 24, 2020
Cap-dependent endonuclease inhibitors
TAIGEN BIOTECHNOLOGY CO LTD2 citations68
US10377714B2Aug 13, 2019
Trans-isomeric heterocyclic compounds and preparation thereof
TAIGEN BIOTECHNOLOGY CO LTD0 citations48
US7378524B2May 27, 2008
Aminoquinoline compounds
TAIGEN BIOTECHNOLOGY CO LTD1 citations48